Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Maves vs TeleHealth Weight Solutions

Maves
Graded #89

Higher grade

vs+10.699999999999996
TeleHealth Weight Solutions
Graded #302

Lower grade

The verdict

Maves takes it — 71.8/100 to 61.1/100.

Maves grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Maves, operating under parent company Homera Health, is a performance-framed telehealth platform offering compounded semaglutide and tirzepatide for weight loss plus sermorelin for anti-aging, with…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMaves +39
84
45
Dose & formulationTeleHealth Weight Solutions +7
65
72
Clinical oversightEven
76
76
Labs & monitoringEven
52
52
FulfillmentMaves +20
87
67
Contract termsEven
55
55
Maves · left barTeleHealth Weight Solutions · right bar

The numbers

MetricMavesTeleHealth Weight Solutions
WeighScore71.8/10061.1/100
GradeCC
Scorecard rank#89#302
Semaglutide$99/mo (starting dose, first-month rate, compounded)$325/mo (all doses, compounded)
TirzepatideNot disclosed$375/mo
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Maves

Graded #89 · C

Strengths

  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer
  • $99/mo first-month intro pricing on semaglutide — among the most aggressive we track
  • All 50 states covered, stated explicitly
  • Both brand (Maves) and parent (Homera Health) disclosed for accountability

Where it loses points

  • 503A pharmacy partner not named (only 'licensed U.S. pharmacies')
  • Tirzepatide pricing not stated on the homepage — only listed as an offering
  • Named medical director / clinical leadership not disclosed
  • Refund and cancellation policy not detailed publicly
  • Corporate address and arbitration venue not disclosed

Strengths

  • Both compounded semaglutide and tirzepatide offered with published pricing
  • Low refill pricing (from about 60 dollars per month) after the initial supply
  • Broad advertised reach across 43 states with home delivery of medication and supplies

Where it loses points

  • Dispensing pharmacy is not publicly named
  • Specific states served are not listed and the site also shows a separate Medi Health Clinics brand
  • 125-dollar transfer fee for outside prescriptions

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard